We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SILV
8801
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$26K ﹤0.01%
+10,409
New +$25.4K
GNMX
8802
CALL
DELISTED
Aevi Genomic Medicine Inc
GNMX
$26K ﹤0.01%
+21,000
New +$23.5K
QTRH
8803
DELISTED
Quarterhill Inc. Common Shares
QTRH
$26K ﹤0.01%
+18,585
New +$24.1K
ANFI
8804
CALL
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$26K ﹤0.01%
+15,400
New +$28.5K
TST
8805
DELISTED
TheStreet, Inc.
TST
$26K ﹤0.01%
+1,172
New +$25.9K
BORN
8806
DELISTED
China New Borun Corporation
BORN
$26K ﹤0.01%
20,628
+9,413
+84% +$10.7K
HOV icon
8807
PUT
Hovnanian Enterprises
HOV
$791M
$25K ﹤0.01%
620
-2,804
-82% -$114K
PXS icon
8808
Pyxis Tankers
PXS
$52.2M
$25K ﹤0.01%
6,663
+845
+15% +$3.07K
UPL
8809
CALL
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$25K ﹤0.01%
22,000
-7,700
-26% -$11.4K
ARDM
8810
DELISTED
Aradigm Corp Common Stock
ARDM
$25K ﹤0.01%
+22,216
New +$30.3K
CRMD icon
8811
CorMedix
CRMD
$621M
$24K ﹤0.01%
4,915
-3,417
-41% -$8.4K
KOPN icon
8812
CALL
Kopin
KOPN
$985M
$24K ﹤0.01%
+10,000
New +$25.4K
PLX icon
8813
Protalix BioTherapeutics
PLX
$184M
$24K ﹤0.01%
3,300
-5,912
-64% -$29.7K
XELB icon
8814
Xcel Brands
XELB
$6.54M
$24K ﹤0.01%
+1,013
New +$25.1K
AGRX
8815
DELISTED
Agile Therapeutics
AGRX
$24K ﹤0.01%
+32
New +$23.4K
TRQ
8816
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
$24K ﹤0.01%
1,110
-1,560
-58% -$39K
FGP
8817
DELISTED
Ferrellgas Partners, L.P.
FGP
$24K ﹤0.01%
10,974
-25,234
-70% -$79.1K
AREX
8818
CALL
DELISTED
Approach Resources Inc.
AREX
$24K ﹤0.01%
+10,800
New +$24.5K
CASM
8819
DELISTED
CAS Medical Systems, Inc.
CASM
$24K ﹤0.01%
+10,453
New +$22.3K
AIM
8820
AIM ImmunoTech
AIM
$6.96M
$24K ﹤0.01%
24
+11
+85% +$13.4K
AMTX icon
8821
Aemetis
AMTX
$126M
$23K ﹤0.01%
22,187
+7,896
+55% +$10.3K
HDSN
8822
PUT
Hudson Technologies
HDSN
$239M
$23K ﹤0.01%
17,800
-4,400
-20% -$7.8K
AGPU
8823
Axe Compute Inc
AGPU
$97.7M
$23K ﹤0.01%
+7
New +$24.1K
SCPX
8824
DELISTED
Scorpius Holdings, Inc.
SCPX
0
FRTX
8825
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$23K ﹤0.01%
53
-7
-12% -$2.95K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.